CDCA5 and cancer: The results showed that the protein expression of CDCA5 in MDA-ME-231 and BT549 cells in the control group was significantly higher than that in the negative control group (P < 0.05); that is, the expression of CDCA5 in TNBC cancer cells was higher than that in normal breast cells.